DEBT CONVERSION AGREEMENTDebt Conversion Agreement • March 28th, 2017 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • New York
THIS DEBT CONVERSION AGREEMENT (this “Agreement”) made as of the date set forth on the signature page hereto (the “Agreement Date”) between PROTEA BIOSCIENCES GROUP, INC., a Delaware corporation (the “Company”), and the Person who has executed this Agreement under the designation “Investor” on the signature page of this Agreement (the “Investor”).
